1 Min Read
Feb 9 (Reuters) - Jubilant Life Sciences Ltd:
* UNIT, JUBILANT PHARMA GETS ANDA FINAL APPROVAL FOR AMANTADINE HYDROCHLORIDE TABLETS, GENERIC VERSION OF SYMMETREL OF ENDO Source text: bit.ly/2EtLooJ Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.